Startup Showcase: Arete Medical Technologies – Revolutionizes Chronic Disease Management

1 min read

Arete Medical Technologies is a precision medicine startup based in Cambridge, UK, that is tackling the challenge of managing chronic diseases, starting with asthma and COPD. These conditions are responsible for millions of deaths globally, and traditional treatments can be expensive, inconvenient, and often inadequate. Arete Medical Technologies is developing a suite of medical devices and software to provide clinicians and patients with accurate, affordable, and real-time data to optimize care decisions.

Introducing the Respicorder

The Respicorder is the first-of-its-kind handheld device that combines several lung function and inflammation tests into one easy-to-use package. This device is a game-changer for chronic disease management because it provides real-time, comprehensive, and affordable data that can help to identify early signs of disease progression, track patient responses to treatment, and optimize medication dosing.

The Respicorder is different from current devices on the market because it uses a unique combination of three key tests: spirometry, FeNO, and impulse oscillometry. These tests measure different aspects of lung function and inflammation, and when combined, provide a more comprehensive picture of the lungs’ health than when each test is done individually.

Cutting Costs and Expanding Access

The Respicorder is not only more comprehensive than traditional devices, but it is also significantly more affordable, and therefore accessible to patients globally. Arete Medical Technologies has several patent-pending innovations that have allowed them to package a room-sized pulmonary function lab into a handheld device, reducing the net cost of testing by approximately 5-10x.

Read more from UKT News:  Is Revolutionary Fintech Transforming Personal Finance and Payroll Practices?

The compact Respicorder can be deployed directly to the patient, eliminating the need for expensive and time-consuming visits to medical facilities. This device is particularly useful for remote monitoring, enabling doctors to track their patient’s lung health in real-time, and providing early detection of disease progression, which can lead to much better clinical outcomes.

Arete Medical Technologies’ Mission

Arete Medical Technologies’ mission is to improve the quality of life of patients with chronic diseases by providing real-time, comprehensive, and affordable data through medical devices and software. They plan to expand their technology into other chronic disease areas, such as cystic fibrosis and chronic obstructive pulmonary disease, where precision approaches are paramount.

Conclusion

Arete Medical Technologies is on a mission to revolutionize the way we manage chronic diseases. Their innovative Respicorder provides clinicians and patients with the comprehensive and real-time data they need to optimize treatment decisions. By reducing the cost and increasing accessibility of these tests, Arete Medical Technologies is creating a future in which chronic diseases can be managed more effectively, with better outcomes and a significantly lower burden on patients and healthcare systems.

Website: http://www.aretemedtech.com

Twitter: https://twitter.com/AreteMedTech

Facebook: https://www.facebook.com/AreteMedTech

LinkedIn: https://www.linkedin.com/company/arete-medical-technologies/


Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on UKT.news. Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.

Read more from UKT News:  Who Are the Most Influential Email Startups Revolutionizing UK's Tech Scene?

UKT News

UKT.news is a media platform owned by Unstructured Media, providing the latest news and insights on UK technology and startup scenes. The website offers readers with daily updates on the latest industry developments, as well as featuring exciting startups and advertising opportunities.

Leave a Reply

Your email address will not be published.